News
Former FDA Commissioner Dr. David Kessler has just released an important new book on diet and wieght loss. He spoke to Forbes ...
Outfit? Check. Glassy skin? Check. Glam life as a bridal stylist with a quarter of a million TikTok followers? Check. In so ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Losing weight after a years-long struggle, this letter writer gave credit to the method — then came the judgmental comments.
Among patients with diabetes who underwent PCI after an acute heart attack, those taking a GLP-1 had better survival rates ...
Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report ...
While natural approaches to raising GLP-1 are not as potent as medications, they provide a drug-free approach to weight loss ...
Trials have confirmed the efficacy of GLP-1 RAs in achieving clinically sustained weight loss in people with obesity without diabetes.
9h
HealthDay on MSNRisk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric SurgeryGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being ...
You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...
3d
Axios on MSNExclusive: Oikos adds protein shakes geared to GLP-1 usersHigh-protein yogurt brand Oikos is expanding beyond the dairy aisle with protein shakes geared to GLP-1 users, Danone North ...
Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results